The expression level of paraoxonases in cervical dysplastic processes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study the level of expression of paraoxonases (PONs) in the cervical epithelium of healthy women and that of female patients with cervical dysplastic processes. To comparatively analyze the expression level of PON1, PON2, and PON3 between the groups. To identify the relationship of changes in the level of expression of PONs to the development of cervical dysplastic processes. Subjects and methods. The investigation covered 47patients who were divided into 3 groups: 1) 16patients with CIN I-II; 2) 17 patients with CINII-III; 3) 14 healthy women. The expression of paraoxonases was analyzed by real-time PCR using primers specific to these genes. Results. The authors found a significant increase in the expression level of the PON3 gene in the cervical epithelium of women with cervical dysplastic processes compared to the control group. There were no significant differences in the level of PON2 expression between the two groups. PON1 gene expression was unidentified in all the samples. Conclusion. During the investigation, the authors found a clear relationship between the higher expression of PON3 and the presence of CIN. The findings suggest that the enzyme PON3 may play a role in the development of dysplastic processes; therefore, determination of the level of PON3 expression may possess certain clinical potential in the diagnosis of precancerous cervical diseases. Thus, further researches in this area are required to develop new prognostic markers for the diagnosis of cervical dysplasia and diagnostic markers for the transition of CIN to cancer, wh ich will be able to improve the quality of early diagnosis of precancerous diseases of the cervix and to optimize differentiated treatment policy.

Full Text

Restricted Access

About the authors

Sergey Aleksandrovich Levakov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: levakofT@yandex.ru
MD, PhD, professor, head of the Department of Obstetrics and Gynecology

Natalya Alekseevna Sheshukova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: dr.sheshukova@mail.ru
MD, PhD, professor of the Department of Obstetrics and Gynecology

Elizaveta Aleksandrovna Obukhova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: liza_obukhova@mail.ru
graduate student of the Department of Obstetrics and Gynecology

N. V Antipova

Academicians M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: Nadine.antipova@gmail.com
Candidate of Biological Sciences, researcher

M. S Pavlyukov

Academicians M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Candidate of Biological Sciences, researcher

M. I Shakhparonov

Academicians M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: shakhparonov@gmail.com
Doctor of Chemical Sciences, Leading Researcher

References

  1. Петрова Г.В. Рак шейки матки. Динамика основных статистических показателей. Исследования и практика в медицине. 2016; 3 (Спецвыпуск: I. Национальный конгресс «Онкология репродуктивных органов: от профилактики и раннего выявления к эффективному лечению» 19-21 мая 2016 года Москва): 134. https://dx.doi. org/10.17709/2409-2231-2016-3-S.
  2. Давыдов М.И., Аксель Е.М., ред. Статистика злокачественных новообразований в России и странах СНГ в 2012 году. М.: Издательская группа РОНЦ; 2014.
  3. Наврузова В.С. Анализ результатов хирургического лечения рака шейки матки пациенток фертильного возраста. Опухоли женской репродуктивной системы. 2015; 11(3): 87-96. https://dx.doi.org/10.17650/1994-4098-2015-11-3-87-96.
  4. Bermudez A., Neerja B., Eric L. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 2015. 131(Suppl. 2): S88-95. https://dx.doi.org/10.1016/j.ijgo.2015.06.004.
  5. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., eds. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0 IARC CancerBase No. 11. 2012. Available at: http:// globocan.iarc.fr
  6. Абакарова П.Р., Прилепская В.Н. ВПЧ-ассоциированные заболевания шейки матки. Возможности комплексной терапии. Гинекология. 2017; 19(5): 4-9.
  7. Murata M. Inflammation and cancer. Environ. Health Prev. Med. 2018; 23(1): 50. https://dx.doi.org/10.1186/s12199-018-0740-1.
  8. Джалалова П.М., Томилова И.К., Алексахина Е.Л., Лапочкина Н.П. Роль локального оксидативного стресса в патогенезе интраэпителиальной дисплазии и рака шейки матки. Исследования и практика в медицине. 2016; 3(Спецвыпуск: I. Национальный конгресс «Онкология репродуктивных органов: от профилактики и раннего выявления к эффективному лечению» 19-21 мая 2016 года Москва): 68-9. https://dx.doi.org/10.17709/2409-2231-2016-3-S.
  9. Gupta R.K., Patel A.K., Shah N., Chaudhary A.K., Jha U.K., Yadav U.C. et al. Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac. J. Cancer Prev. 2014; 15(11): 4405-9. https://dx.doi.org/10.7314/ apjcp.2014.15.11.4405.
  10. Ebrahimi S., Soltani A., Hashemy S.I. Oxidative stress in cervical cancer pathogenesis and resistance to therapy. J. Cell. Biochem. 2018; Nov 13. https:// dx.doi.org/10.1002/jcb.28007
  11. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012; 24(5): 981-90. https:// dx.doi.org/10.1016/j.cellsig.2012.01.008.
  12. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002; 82(1): 47-95.
  13. Кормош Н.Г. Физиологическая роль активных форм кислорода (субклеточный уровень) - взгляд клинициста. Российский биотерапевтический журнал. 2011; 10(4): 29-35.
  14. Боровкова Е.И., Антипова Н.В., Корнеенко Т.В., Шахпаронов М.И., Боровков И.М. Параоксоназа: универсальный фактор антиоксидантной защиты организма человека. Вестник Российской академии медицинских наук. 2017; 72(1): 5-10.
  15. Ефимцева Э.А., Челпанова Т.И. Параоксоназа: молекулярно-генетические аспекты и клиническое значение. Успехи современной биологии. 2012; 132(3): 282-96.
  16. Furlong C.E., Marsillach J., Jarvik G.P., Costa L.G. Paraoxonases-1, -2 and -3: What are their functions? Chem. Biol. Interact. 2016; 259(Pt B): 51-62. https:// dx.doi.org/10.1016/j.cbi.2016.05.036.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies